Genesis Regenerative launches a three-step roadmap for clinicians

Genesis Regenerative has introduced the Roadmap to Health, a new clinical framework that combines genomic testing, regenerative proteins and peptide therapy across the company’s network. The rollout is designed to help clinicians personalize care, extend support beyond a single treatment and match advanced diagnostics with regenerative protocols.

Why it matters: - Genesis Regenerative is packaging diagnostics, regenerative biologics and maintenance support into one clinical workflow. - The company is positioning the Roadmap to Health as a way to make personalized care more practical for clinicians already using regenerative therapies. - The launch could expand how Genesis-supported practices handle assessment, treatment and follow-up in one system.

What happened: - Genesis Regenerative launched the Roadmap to Health on August 25, 2026. - The program is available now to clinicians across the Genesis network. - The company describes the framework in three stages: Assess, Repair and Maintain. - The roadmap combines genomic testing, healing proteins and peptide therapy into a single care model.

The details: - The first stage uses pharmacogenomic and nutrigenomic testing. - Those panels are designed to show how a patient responds to prescriptions, diet, exercise and environmental factors. - Genesis says that approach lets clinicians build a plan around the individual rather than the presenting symptom. - The second stage uses the Regenerative Protein Array, the company’s preparation of healing proteins. - The third stage uses a needle-free transdermal patch that delivers peptides and therapeutics such as NAD+. - Genesis says the patch is meant to give clinicians an option at the point where a course of care would otherwise end. - The Roadmap follows guidance from the company’s medical leadership. - Members of Genesis Medical Directors and the Clinical Advisory Board have reported better and more durable outcomes when advanced diagnostic testing and support therapies are used alongside regenerative therapies. - Dr. Robert Kornfeld, a member of the Genesis Regenerative Clinical Advisory Board, has argued for a whole-patient approach for decades. - Kornfeld entered private practice in 1982 as a conventional foot and ankle surgeon. - Kornfeld has taught clinicians through the Institute for Functional Podiatric Medicine. - Kornfeld said he began his career in a traditional paradigm and later moved toward a more holistic approach after a personal experience. - Kornfeld said regenerative medicine should signal the immune system to enter repair mode and that maintenance protocols should help preserve healing. - Genesis says the roadmap gives clinicians access to assessment and maintenance tools alongside regenerative therapy. - The company says the offering extends its support and education model beyond a single product. - More information is available in the company’s announcement.

Between the lines: - The launch reflects a broader push to connect diagnostics with treatment, rather than selling regenerative products in isolation. - Genesis is leaning on board-level clinical experience to support a more systematized care model. - The Roadmap also appears designed to deepen clinician loyalty by adding workflow support, education and follow-through.

What's next: - Genesis will continue offering the Roadmap to Health to clinicians in its network. - The company is likely to use the framework to reinforce adoption of its regenerative products and related support services. - Kornfeld’s clinical philosophy suggests Genesis may continue building around whole-patient assessment and maintenance care.

The bottom line: - Genesis Regenerative is turning regenerative medicine into a staged care pathway, with testing, treatment and maintenance under one umbrella.